Update on Angiomax(R) (Bivalirudin) Patent Litigation

Update on Angiomax(R) (Bivalirudin) Patent Litigation

[Marketwired] – The Medicines Company — On March 31, 2014, Judge Andrews in the U.S. District Court of Delaware issued his Trial Opinion in The Medicines Company v. Hospira, Inc. The case involves Hospira’s Abbreviated … more

View todays social media effects on MDCO

View the latest stocks trending across Twitter. Click to view dashboard

See who The is hiring next, click here to view

Share this post